Profile banner
Cindy Chung

Cindy Chung

Principal Engineer — formulation & drug product development

Cindy
Bend, Oregon
Joined May 2024
Favicon imageseranbio.com
Favicon imageseranbio.com
Favicon imageaaps2024.eventscribe.net
Favicon imagestanford.edu
Favicon imageresearchgate.net
Favicon imagelinkedin.com

Network

1.1K connections
🧬
Serán BioScience Core
🧪
Biopharma R&D Process
🤖
AI/ML Tech Innovators
⚖️
Clinical Regulatory Affairs
📚
Academic Research Faculty
💡
Biotech Founders Leaders
🎓
Stanford Network

Summary

Applied formulation scientist focused on high‑concentration biologics and suspension approaches. At Serán BioScience she is described as Principal Engineer in formulation and product/process development and has presented multiple case studies on spray‑dried protein suspensions, vehicle selection, and dispense‑force optimization to enable subcutaneous delivery at very high protein concentrations. seranbio+1
Strong academic background in biomaterials and tissue engineering, with a Ph.D. from the University of Pennsylvania and postdoctoral experience in the Heilshorn group at Stanford. Her academic work focused on photocrosslinkable hyaluronic acid hydrogels, degradation behavior, and cell‑material interactions—skills that translate into formulation and particle engineering in industry. upenn+1
Career trajectory from academic biomaterials research into industry/CDMO roles. Publications and lab listings from her PhD/postdoc period tie to translational biomaterials expertise, and more recent Serán BioScience materials and conference listings show she applies that background to real‑world formulation and drug‑product development problems. researchgate+2

Work

Education

Projects

Writing

Development and Characterization of Photocrosslinkable Hyaluronic Acid Hydrogels for Cartilage Regeneration

January 1, 2009

Doctoral dissertation / related work describing synthesis, photocrosslinking, and characterization of methacrylated hyaluronic acid hydrogels for cartilage tissue engineering and studies of chondrocyte/MSC behavior in 3D HA matrices.

Favicon imageseas.upenn.edu

High Concentration Bevacizumab for Subcutaneous Delivery (presentation)

Conference presentation/case study describing spray‑dried protein suspensions as a platform for ultra‑high concentration subcutaneous delivery and associated formulation/process optimization.

Favicon imageseranbio.com

Notes

ATAlex Teichmansaid
CCCindy Chung
has driven major innovations in research and development at a leading pharmaceutical or R&D company.

Dec 14, 2025